Please assess the completion status of the following clinical trial:

Trial Title: Protego DF4 Post Approval Registry

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Implanted within the last 30 days or candidate for implantation of a BIOTRONIK ICD or CRT-D DF4 compatible system along with the Protego DF4 lead~* Meets ICD or CRT-D system implant recommendations as defined in guidelines published by relevant professional societies~* Able to understand the nature of the registry and provide informed consent~* Available for follow-up visits on a regular basis at the investigational site for the expected 5 years of follow-up~* Age greater than or equal to 18 years~Exclusion Criteria:~* Enrolled in any investigational cardiac device trial~* Planned cardiac surgical procedures or interventional measures within the next 6 months~* Expected to receive heart transplantation or ventricular assist device within 1 year~* Life expectancy of less than 1 year~* Presence of another life-threatening, underlying illness separate from their cardiac disorder~* Patients reporting pregnancy at the time of enrollment

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).